Redefining Dermatology Through Accessibility and Rapid Data Analysis

MedX enables highly accurate skin assessments by delivering data (multiple sub dermal image views of skin and meta data) to online clinicians with immediacy.

Our fully FDA-approved, Health Canada, CE-accredited DermSecure platform and FDA-approved Medical Devices deliver functional and dynamic Electronic Health Records (together with analytical tools).

MedX’s DermSecure platform is built as extensible and interoperable, allowing for safe and secure data sharing across 38 territories worldwide.

Proven and resilient, clinicians and testers in multiple Clinical Research Organisations rely on MedX to collect and image collagen, blood and melanin levels.

With over 200,000 scans processed from the UK and Canada to Norway and the Netherlands, MedX continuously enables dermatologists to assess their patients with highly accurate images, providing a 5-sectional analysis of any mole within minutes of a patient being scanned.

MedX has developed a modular software system that is enabled by HL7 FHIR protocols. These protocols underpin our ability to deliver functional interoperability of a patient Electronic Health Record with physicians, providers, employers and health systems.